{"cik":1990550,"taxonomy":"us-gaap","tag":"AmortizationOfIntangibleAssets","label":"Amortization of Intangible Assets","description":"The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.","entityName":"Ambrx Biopharma, Inc.","units":{"USD":[{"start":"2022-01-01","end":"2022-09-30","val":895000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13"},{"start":"2022-07-01","end":"2022-09-30","val":200000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2022Q3"},{"start":"2023-01-01","end":"2023-09-30","val":472000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13"},{"start":"2023-07-01","end":"2023-09-30","val":200000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2023Q3"}]}}